Back to Browse Journals » Vascular Health and Risk Management » Volume 6

An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog

Authors Katarina Raslova

Published 24 May 2010 Volume 2010:6 Pages 399—410


Review by Single-blind

Peer reviewer comments 6

Katarina Raslova

Metabolic Center Ltd and Slovak Medical University, Bratislava, Slovak Republic

Abstract: Basal insulin analogs are used to minimize unpredictable processes of NPH insulin. Modification of the human insulin molecule results in a slower distribution to peripheral target tissues, a longer duration of action with stable concentrations and thus a lower rate of hypoglycemia. Insulin detemir is a basal insulin analog that provides effective therapeutic options for patients with type 1 and type 2 diabetes. For glycemic control, no significant differences were found in HbA1c levels compared with NPH and insulin glargine. It is comparable with insulin glargine in significantly reducing rates of all types of hypoglycemia. Clinical studies have demonstrated that detemir is responsible for significantly lower within-subject variability and no or less weight gain than NPH insulin and glargine. Recent pharmacodynamic studies have shown that detemir can be used once daily in many patients with diabetes. Together with patient-friendly injection devices and dose adjustments, it provides a treatment option with the potential to lower the key barriers of adherence to insulin therapy in type 2 diabetes. Recent guidelines for treatment of type 2 diabetes suggest starting intensive therapy of hyperglycemia at an early stage of diabetes and recommend therapeutic options that provide the possibility of reaching HbA1c goals individually, with a low risk of hypoglycemia or other adverse effects of treatment. The properties of insulin detemir match these requirements.

Keywords: insulin analog, insulin detemir, diabetes mellitus, hypoglycemia, within-subject variability

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Drug-eluting scaffold to deliver chemotherapeutic medication for management of pancreatic cancer after surgery

Zhan Q, Shen B, Deng X, Chen H, Jin J, Zhang X, Peng C, Li H

International Journal of Nanomedicine 2013, 8:2465-2472

Published Date: 11 July 2013

Synthesis of talc/Fe3O4 magnetic nanocomposites using chemical co-precipitation method

Kalantari K, Bin Ahmad M, Shameli K, Khandanlou R

International Journal of Nanomedicine 2013, 8:1817-1823

Published Date: 15 May 2013

Surgical management of hypotropia in congenital fibrosis of extraocular muscles (CFEOM) presented by pseudoptosis

Tawfik HA, Rashad MA

Clinical Ophthalmology 2013, 7:1-6

Published Date: 20 December 2012

Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle

Chen JP, Yang PC, Ma YH, Tu SJ, Lu YJ

International Journal of Nanomedicine 2012, 7:5137-5149

Published Date: 27 September 2012


Marusza W, Mlynarczyk G, Olszanski R, Netsvyetayeva I, Obrowski M, Iannitti T, Palmieri B

International Journal of Nanomedicine 2012, 7:4119-4120

Published Date: 27 July 2012

Tat peptide-admixed elastic liposomal formulation of hirsutenone for the treatment of atopic dermatitis in Nc/Nga mice

Kang MJ, Eum JY, Jeong MS, Park SH, Moon KY, Kang MH, Kim MS, Choi SE, Lee MW, Lee DI, Bang H, Lee CS, Joo SS, Li K, Lee M-K, Seo SJ, Choi YW

International Journal of Nanomedicine 2011, 6:2459-2467

Published Date: 20 October 2011

Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly

Adriana Lima Vallochi, Anna Carla Goldberg, Angela Falcai, Rajendranath Ramasawmy, Jorge Kalil, et al

Clinical Ophthalmology 2008, 2:837-848

Published Date: 5 December 2008

Histology of corneal wound healing after deep lamellar endothelial keratoplasty

Chaoran Zhang, Jianjiang Xu, Rongjia Chen

Clinical Ophthalmology 2008, 2:217-221

Published Date: 7 March 2008